EP1144397A3 - Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group - Google Patents
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine groupInfo
- Publication number
- EP1144397A3 EP1144397A3 EP99963023A EP99963023A EP1144397A3 EP 1144397 A3 EP1144397 A3 EP 1144397A3 EP 99963023 A EP99963023 A EP 99963023A EP 99963023 A EP99963023 A EP 99963023A EP 1144397 A3 EP1144397 A3 EP 1144397A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- herpes viruses
- heterocyclic carboxamide
- phenylenediamine group
- thiourea inhibitors
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 title 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical group NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 title 1
- -1 Heterocyclic carboxamide Chemical class 0.000 title 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241001529453 unidentified herpesvirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20855998A | 1998-12-09 | 1998-12-09 | |
US208559 | 1998-12-09 | ||
PCT/US1999/028842 WO2000034258A2 (en) | 1998-12-09 | 1999-12-06 | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1144397A2 EP1144397A2 (en) | 2001-10-17 |
EP1144397A3 true EP1144397A3 (en) | 2002-09-11 |
Family
ID=22775044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99963023A Withdrawn EP1144397A3 (en) | 1998-12-09 | 1999-12-06 | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1144397A3 (pt) |
JP (1) | JP2002531554A (pt) |
CN (1) | CN1348446A (pt) |
AU (1) | AU1934700A (pt) |
BG (1) | BG105581A (pt) |
BR (1) | BR9916046A (pt) |
CA (1) | CA2350767A1 (pt) |
CZ (1) | CZ20011956A3 (pt) |
EA (1) | EA200100631A1 (pt) |
HU (1) | HUP0200232A2 (pt) |
ID (1) | ID30158A (pt) |
IL (1) | IL143182A0 (pt) |
NO (1) | NO20012832L (pt) |
PL (1) | PL349217A1 (pt) |
SK (1) | SK7682001A3 (pt) |
TR (1) | TR200101664T2 (pt) |
WO (1) | WO2000034258A2 (pt) |
ZA (1) | ZA200104377B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6166028A (en) * | 1998-12-09 | 2000-12-26 | American Home Products Corporation | Diaminopuridine-containing thiourea inhibitors of herpes viruses |
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
US6376515B2 (en) | 2000-02-29 | 2002-04-23 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor Xa |
US7220768B2 (en) * | 2003-02-11 | 2007-05-22 | Wyeth Holdings Corp. | Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus |
EP2077995B1 (en) | 2006-11-02 | 2012-02-08 | Millennium Pharmaceuticals, Inc. | Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
WO2014070979A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
US9284310B2 (en) | 2012-11-03 | 2016-03-15 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
CN110565100B (zh) * | 2019-07-12 | 2021-05-07 | 西北工业大学 | 一种二茂钴阳离子基缓蚀剂及制备方法和使用方法 |
EP4382527A1 (en) | 2021-08-05 | 2024-06-12 | Zhejiang Hisun Pharmaceutical Co., Ltd. | Aromatic acetylene derivative, and preparation method therefor and use thereof |
WO2023088718A1 (en) | 2021-11-19 | 2023-05-25 | Basf Se | Bicyclic compounds for the control of invertebrate pests |
CN115433093A (zh) * | 2022-09-26 | 2022-12-06 | 无锡双启科技有限公司 | 一种3-氯-4-三氟甲基苯胺的制备方法 |
CN115710190A (zh) * | 2022-11-16 | 2023-02-24 | 常州佳德医药科技有限公司 | 4-甲氧基-2-氨基-n,n-二甲基苯胺、制备方法及应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001519808A (ja) * | 1997-04-10 | 2001-10-23 | ファルマシア・アンド・アップジョン・カンパニー | ポリ芳香族抗菌組成物 |
-
1999
- 1999-12-06 IL IL14318299A patent/IL143182A0/xx unknown
- 1999-12-06 CZ CZ20011956A patent/CZ20011956A3/cs unknown
- 1999-12-06 WO PCT/US1999/028842 patent/WO2000034258A2/en not_active Application Discontinuation
- 1999-12-06 AU AU19347/00A patent/AU1934700A/en not_active Abandoned
- 1999-12-06 EA EA200100631A patent/EA200100631A1/ru unknown
- 1999-12-06 SK SK768-2001A patent/SK7682001A3/sk unknown
- 1999-12-06 TR TR2001/01664T patent/TR200101664T2/xx unknown
- 1999-12-06 EP EP99963023A patent/EP1144397A3/en not_active Withdrawn
- 1999-12-06 BR BR9916046-3A patent/BR9916046A/pt not_active Application Discontinuation
- 1999-12-06 HU HU0200232A patent/HUP0200232A2/hu unknown
- 1999-12-06 PL PL99349217A patent/PL349217A1/xx not_active Application Discontinuation
- 1999-12-06 CA CA002350767A patent/CA2350767A1/en not_active Abandoned
- 1999-12-06 ID IDW00200101231A patent/ID30158A/id unknown
- 1999-12-06 JP JP2000586705A patent/JP2002531554A/ja active Pending
- 1999-12-06 CN CN99815997A patent/CN1348446A/zh active Pending
-
2001
- 2001-05-28 ZA ZA200104377A patent/ZA200104377B/en unknown
- 2001-06-08 BG BG105581A patent/BG105581A/xx unknown
- 2001-06-08 NO NO20012832A patent/NO20012832L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000034258A2 (en) | 2000-06-15 |
JP2002531554A (ja) | 2002-09-24 |
PL349217A1 (en) | 2002-07-01 |
HUP0200232A2 (hu) | 2002-05-29 |
BR9916046A (pt) | 2001-10-02 |
CA2350767A1 (en) | 2000-06-15 |
CZ20011956A3 (cs) | 2001-10-17 |
IL143182A0 (en) | 2002-04-21 |
EP1144397A2 (en) | 2001-10-17 |
ID30158A (id) | 2001-11-08 |
CN1348446A (zh) | 2002-05-08 |
SK7682001A3 (en) | 2002-07-02 |
AU1934700A (en) | 2000-06-26 |
TR200101664T2 (tr) | 2002-03-21 |
NO20012832L (no) | 2001-08-07 |
BG105581A (en) | 2001-12-31 |
WO2000034258A3 (en) | 2001-11-29 |
ZA200104377B (en) | 2002-12-20 |
NO20012832D0 (no) | 2001-06-08 |
EA200100631A1 (ru) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4429799A (en) | Inhibitors of p38 | |
EG24028A (en) | Aminothiazole inhibitors of cyclin dependent kinases | |
AU7705694A (en) | Substituted urea and isothiourea derivatives as no synthase inhibitors | |
AU6718494A (en) | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase | |
IL135574A0 (en) | Substituted 4-amino-thiazol-2-yl compounds as cdk inhibitors | |
PL344046A1 (en) | Heterocyclic inhibitors of p38 | |
ZA985205B (en) | Novel n-substituted urea inhibitors of arnesyl-protein transferase | |
AU8059598A (en) | Heterocyclic amide compounds as cell adhesion inhibitors | |
AU3039995A (en) | Heterocyclic derivatives of N-phenylamides | |
AU2274299A (en) | Benzazine derivatives phosphodiesterase 4 inhibitors | |
AU5619400A (en) | Statine-derived tetrapeptide inhibitors of beta-secretase | |
EP1144397A3 (en) | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group | |
AU3107795A (en) | Inhibitors of the benzamidine type | |
MXPA00012647A (es) | Derivados n-sustituidos de acido 5-oxiiminobarbiturico. | |
AU1605699A (en) | Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii) | |
PL339176A1 (en) | Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase | |
EP1144399A3 (en) | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group | |
IL143262A0 (en) | Thiourea inhibitors of herpes viruses | |
NO20012834D0 (no) | Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus | |
EP0599514A3 (en) | Pyranoquinoline derivatives as inhibitors of cell proliferation. | |
AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
HUP0104492A3 (en) | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group | |
PL339186A1 (en) | Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase | |
IL143261A0 (en) | Thiourea inhibitors of herpes viruses | |
PL348177A1 (en) | Thiourea inhibitors of herpes viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010606 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010606;LT PAYMENT 20010606;LV PAYMENT 20010606;MK;RO PAYMENT 20010606;SI PAYMENT 20010606 |
|
XX | Miscellaneous (additional remarks) |
Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR. |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TEREFENKO, EUGENE, ANTHONY Inventor name: ROSS, ADMA, ANTONIA Inventor name: LANG, STANLEY, ALBERT Inventor name: JONES, THOMAS, RICHARD Inventor name: DUSHIN, RUSSELL, GEORGE Inventor name: DIGRANDI, MARTIN, JOSEPH Inventor name: CURRAN, KEVIN JOSEPH Inventor name: BLOOM, JONATHAN DAVID |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: WYETH |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010606;LT PAYMENT 20010606;LV PAYMENT 20010606;RO PAYMENT 20010606;SI PAYMENT 20010606 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030701 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1037369 Country of ref document: HK |